Explain How Seebri and Utibron Stack Up Against Other Inhalers for COPD

February 2016

Two new bronchodilators, Seebri Neohaler (SEE-bree) and Utibron Neohaler (YOO-tee-bron), will jostle for a place in the COPD market.

They both contain the long-acting anticholinergic, glycopyrrolate...and Utibron combines it with the long-acting beta-agonist, indacaterol.

Think of Seebri as similar to Spiriva (tiotropium), Tudorza (aclidinium), or Incruse (umeclidinium)...and Utibron as similar to Anoro (umeclidinium/vilanterol) or Stiolto (tiotropium/olodaterol).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote